DUBLIN–(BUSINESS WIRE)–The “Artificial Intelligence in Medical Diagnostics Market By Component, Specialty, Modality, End User – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The AI in medical diagnostics market is expected to reach $9.38 billion by 2029, at a CAGR of 36.2% from 2022-2029.
Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities for the AI in medical diagnostics market. The growth of this market is driven by the rising need for the adoption of AI in medical diagnosis due to the high rate of diagnostic errors, the growing shortage of medical specialists, and the increasing prevalence of chronic diseases.
In addition, factors such as high growth potential in emerging economies and the growing number of cross-industry partnerships and collaborations are expected to provide significant growth opportunities for this market.
However, the reluctance of physicians to adopt AI technologies due to a lack of trust is expected to hamper the adoption of AI in medical diagnostics solutions and restrain the growth of this market. In addition, factors such as regulatory barriers and privacy and security concerns are the major challenges to the growth of this market.
Scope of the Report:
AI in Medical Diagnostics Market, by Component
Software
Services
AI in Medical Diagnostics Market, by Specialty
Brain & Neurological
Oncology
Cardiac & Vascular
Chest & Lung
Obstetrics & Gynecology (OB-GYN)
Other Specialties
AI in Medical Diagnostics Market, by Modality
MRI
CT Scan
X-ray
Ultrasound
Other Modalities
AI in Medical Diagnostics Market, by End User
Hospitals
Diagnostic Imaging Centers
Others End Users
AI in Medical Diagnostics Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia Pacific
China
Japan
India
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa
Market Dynamics
Drivers
Growing Need to Incorporate AI into Medical Diagnosis
Shortage of Healthcare Professionals
Rising Incidence of Chronic Diseases
Restraints
Reluctance to Adopt AI Technologies due to a Lack of Trust
Opportunities
High Potential in Emerging Economies
Growing Number of Cross-Industry Partnerships & Collaborations
Challenges
Regulatory Barriers
Privacy & Security Concerns
Companies Mentioned
Siemens Healthineers AG (Germany)
GE Healthcare (U.S.)
Aidoc Medical Ltd. (Israel)
International Business Machines Corporation (U.S.)
AliveCor Inc. (U.S.)
VUNO Inc. (South Korea)
Digital Diagnostics Inc. (U.S.)
NovaSignal Corp. (U.S.)
Riverain Technologies (U.S.)
NANO-X IMAGING LTD (Israel)
Imagen Technologies (U.S.)
Koninklijke Philips N.V. (Netherlands)
Agfa-Gevaert Group (Belgium)
HeartFlow Inc. (U.S.)
Arterys Inc. (U.S.)
For more information about this report visit https://www.researchandmarkets.com/r/axe2dv
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
